Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 8 chart positions in 8 markets.
By chart position
- 🇦🇺AU · Life Sciences#8530K to 100K
- 🇨🇦CA · Life Sciences#1285K to 30K
- 🇬🇧GB · Life Sciences#1635K to 30K
- 🇺🇸US · Life Sciences#1855K to 30K
- 🇩🇪DE · Life Sciences#1965K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
45K to 177K🎙 ~2x weekly·38 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
91K to 353K🇦🇺28%🇻🇳28%🇨🇦8%+5 more - Active Followers
Loyal subscribers who consistently listen
36K to 141K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 12 epsHosts
Recent guests
Recent episodes
Genotoxicity, vectors, and the power of integration site analysis
Jun 17, 2026
Unknown duration
From brewing to bioprocessing – Steve Lewis on molecular biology trends
Jun 8, 2026
22m 45s
Epigenetics unlocked – how behavior shapes biology
May 20, 2026
41m 41s
Multiplexing in action – from simplicity to scientific complexity
May 6, 2026
19m 05s
Finding the cheat codes to cell identity
Apr 15, 2026
33m 18s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/17/26 | Genotoxicity, vectors, and the power of integration site analysis | Integration site analysis is becoming a critical tool in evaluating the safety of gene therapies, but how does it actually work, and when does it matter most? Michael Stump and Matteo Franco of ProtaGene break down the science, the risk, and the evolving role of CROs in this rapidly changing field. | — | ||||||
| 6/8/26 | From brewing to bioprocessing – Steve Lewis on molecular biology trends✨ | molecular biologyPCR+3 | Steve Lewis | Thermo Fisher ScientificSpeaking of Mol Bio | — | molecular biologyPCR+3 | — | 22m 45s | |
| 5/20/26 | Epigenetics unlocked – how behavior shapes biology✨ | epigeneticsgene expression+3 | Dr. Robert Philibert | Absolute Gene-ius | — | epigeneticsgene expression+4 | — | 41m 41s | |
| 5/6/26 |  Multiplexing in action – from simplicity to scientific complexity✨ | PCR multiplexingDNA targets+4 | — | PCR | — | PCR multiplexingDNA+5 | — | 19m 05s | |
| 4/15/26 | Finding the cheat codes to cell identity✨ | cell identityinduced pluripotent stem cells+3 | Fiona Connolly | bit.bio | — | cell identityiPSCs+5 | — | 33m 18s | |
| 4/1/26 |  Science happens, and so do mistakes✨ | lab failuresscience mishaps+3 | — | — | — | lab failscience+3 | — | 14m 17s | |
| 3/18/26 | Almost a virus – how AAV powers modern gene therapy✨ | gene therapyviral vectors+4 | Dr. Dan Mitchell | Matica BiotechnologyCDMO+2 | — | gene therapyAAV+6 | — | 32m 59s | |
| 3/4/26 | How sequencing and PCR work together in oncology research✨ | oncology researchliquid biopsy+4 | Dr. Kathie Sollweck | Thermo Fisher Scientific | — | oncologyliquid biopsy+5 | — | 33m 08s | |
| 2/18/26 |  When PCR gets dirty - tackling PCR inhibitors✨ | PCR inhibitorsenvironmental testing+4 | — | Absolute Gene-iusdigital PCR | — | PCR inhibitorsenvironmental testing+4 | — | 11m 47s | |
| 2/5/26 | Tracking grape pathogens from air to vine✨ | grape pathogensmolecular tools+5 | Lexi Heger | Michigan State University | — | grape pathogensqPCR+5 | — | 36m 15s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 1/14/26 | Season 4 – new voices, new discoveries✨ | molecular biologydigital PCR+3 | — | Absolute Gene-ius | — | molecular biologydigital PCR+5 | — | 6m 27s | |
| 8/20/25 | Digital PCR and the fight against HIV-2 and superbugs✨ | digital PCRHIV-2+3 | Dr. Jesús Mingorance | HIV-2superbugs | — | digital PCRHIV-2+4 | — | 35m 11s | |
| 7/23/25 | Biomarkers in motion ― detecting Alzheimer's through saliva✨ | Alzheimer's diseasebiomarkers+4 | Arianna Arbona | — | — | Alzheimer'sbiomarkers+5 | — | 32m 34s | |
| 6/18/25 | Python problems – digital PCR takes on the Everglades | Join us for a wild ride with Dr. Brian Bahder, who’s applying digital PCR to track invasive snakes and megafauna across South Florida. From childhood bug collections to bushmaster selfies, he blends passion, fieldwork, and scientific rigor in one unforgettable episode. | — | ||||||
| 5/21/25 | Life finds a way – copy number variation and drug metabolism | In this episode of Absolute Gene-ius, pharmacogenetic laboratory supervisor Wendy Wang takes us on a journey through the fascinating field of pharmacogenomics. Learn how digital PCR is advancing our understanding of drug metabolism, particularly through the study of the CYP2D6 gene, and gain insights into Wendy’s unique career path from history major to leading scientist. | — | ||||||
| 4/16/25 | Unlocking cancer’s genetic secrets with digital PCR | We dive into the world of digital PCR and cancer research with Valeria Rangel, a PhD candidate at UC Irvine. Val shares how her lab is using dPCR to uncover genetic and epigenetic factors driving acute lymphoblastic leukemia in Hispanic populations, while also reflecting on her journey into science and the power of perseverance in research. | — | ||||||
| 3/19/25 | CRISPR, dPCR, and pigs – a cut above the rest | In this episode of Absolute Gene-ius, Dr. C. Dustin Rubinstein, Director of the Advanced Genome Editing Laboratory at the University of Wisconsin-Madison, shares how CRISPR and digital PCR are revolutionizing genome editing and disease research. From developing pig models for cancer studies to refining gene-editing confirmation with dPCR, he highlights the power of precise quantification and the collaborative nature of cutting-edge molecular biology. | — | ||||||
| 2/26/25 | Season two amplified – reflections and takeaways | In this Season 2 recap our hosts revisit some highlights, from using dPCR for low-cost screening in single-cell sequencing to mRNA quantification breakthroughs. They reflect on guest insights, the complementary roles of dPCR and qPCR, and their growing synergy in molecular workflows. Join the team as they celebrate another successful season and add primers for the upcoming Season 3. | — | ||||||
| 10/30/24 |  The Poisson perspective – counting out false positives | We return to the topic of Poisson statistics do delve a bit deeper into how digital PCR handles topics like false positives or ow abundance and rare targets. Dave Bauer is once again our statistics and math guru that brings his easy talking ways along with a depth of experience to give real-world examples that drive the concepts home. | — | ||||||
| 10/16/24 | Somatic mosaic loss of sex chromosomes and kidney disease | Parker Wilson has taken a sometimes-unpredictable path to obtain his MD and PhD degrees and establish his physician scientist career, but he’s been quick to adopt and apply the molecular genetic pathology tools that are changing his field. Join us to hear about his exciting work where he uses digital PCR and NGS methods to identify and quantify rare mutations associated with kidney disease. | — | ||||||
| 9/23/24 |  Automating accuracy – an insider’s view | Automation is key to enabling high-throughput analysis for any analytical method, and automation of digital PCR (dPCR) is now a reality. Join us for this conversation with Dr. Clarence Lee, Senior Product Manger, about how Thermo Fisher is delivering the benefits of dPCR, along with high-throughput automation that saves time and enables diverse application areas. | — | ||||||
| 9/4/24 | Helping democratize access and use of mRNA technology | The use of mRNA as a vaccine platform has been mostly derisked and its speed to move from antigen discovery to drug product is impressive. However, high-purity mRNA can still be a challenge to make. Dr. Christian Cobaugh, CEO of Vernal Biosciences, is on a mission to make high-purity mRNA available to more researchers and drug developers to help realize even more potential from mRNA medicines. | — | ||||||
| 8/14/24 | Now that’s what I call a high-quality viral vector | We dive deep into gene therapy during this conversation with Dr. Cliff Froelich. He covers what vectors his team works with, what methods and technologies they use to monitor quality and safety, and he reminds us why it all matters. As always, you’ll get a bit of fun too! | — | ||||||
| 6/5/24 | Ch-ch-ch-ch-changes | Now that we’re 15 episodes deep into this series, and because life is forever changing, we thought we’d take a moment to reflect on where we are, how we got here, and talk about what’s to come. Witness the evolution of the series! | — | ||||||
| 5/15/24 | What’s your vector, Victor? | Curious about cell and gene therapy and the viral vectors used in these applications? If so, join us for a conversation with a couple of resident experts that shed light on these topics. | — | ||||||
Showing 25 of 42
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
9 placements across 8 markets.
Chart Positions
9 placements across 8 markets.